β-Thalassemia gene editing therapy: Advancements and difficulties
Jing Hu,Yebing Zhong,Pengxiang Xu,Liuyan Xin,Xiaodan Zhu,Xinghui Jiang,Weifang Gao,Bin Yang,Yijian Chen
DOI: https://doi.org/10.1097/md.0000000000038036
IF: 1.6
2024-05-05
Medicine
Abstract:β-Thalassemia is an inherited disorder of hemoglobin (Hb) production, resulting in ineffective erythropoiesis. [ 1 ] Chronic hemolysis is the predominant symptom, with clinical signs of myeloproliferative, extramedullary hematopoiesis, and iron homeostasis disorders. [ 1 ] Patients with thalassemia suffer from the most common monogenic hereditary disease worldwide and also represent the largest monogenic hereditary disease in China. [ 2 ] It originates from the Mediterranean, the Middle East, and Southeast Asia. The disease has a widespread distribution among populations and affects a large number of individuals, with an estimated carrier rate of the β-thalassemia gene at around 1.5% globally. [ 3 ] β-Thalassemia is classified as nontransfusion dependent β-thalassemia or transfusion-dependent β-thalassemia (TDT) on the basis of transfusion requirements. [ 4 ] Regular transfusion is the mainstay of treatment for patients with TDT; however, it brings with it iron loading related to transfusion, increased irreversible end-organ toxicity, and adverse effects of iron chelators. Hematopoietic stem cell transplantation is the only treatment, and gene editing therapy has opened the door to a cure for β-thalassemia patients. In recent years, gene editing has been developed rapidly and applied widely, such as applying mature gene-addition technology, directly repairing defective β-pearl protein genes on autologous HSCs such as zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and especially the emerging CRISPR-Cas9 genome editing technology, or activating other genes that can replace the function of β-pearl proteins. Here, we review the emerging gene therapy modalities for the treatment of thalassemia and the possibilities for future directions.
medicine, general & internal